Article
Targeting TGF-β-Smad2/3-JNK1-mediated SIRT1 activity overcomes the chemoresistance of KRAS mutation lung cancer
2024-11-20
Abstract excerpt
<title>Abstract</title> <p>Lung cancer patients with a KRAS oncogenic driver mutation have a very poor prognosis. Recently, we reported that SIRT1 is upregulated by the KRAS<sup>Mut</sup>-c-Myc-axis and KRAS<sup>Mut</sup>-induced SIRT1 stably deacetylated by lysine 104 and increased KRAS<sup>Mut</sup> activity, enhancing chemoresistance. Of note, SIRT1 activity, as well as SIRT1 levels are more increased in KRAS<...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0116388d-244c-5f91-8e1e-5619cb4b7605
- DOI
- 10.21203/rs.3.rs-5237268/v1
